BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 23661792)

  • 21. Vaccine schedules and the effect on humoral and intestinal immunity against poliovirus: a systematic review and network meta-analysis.
    Macklin GR; Grassly NC; Sutter RW; Mach O; Bandyopadhyay AS; Edmunds WJ; O'Reilly KM
    Lancet Infect Dis; 2019 Oct; 19(10):1121-1128. PubMed ID: 31350192
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of different vaccination schedules on excretion of oral poliovirus vaccine strains.
    Laassri M; Lottenbach K; Belshe R; Wolff M; Rennels M; Plotkin S; Chumakov K
    J Infect Dis; 2005 Dec; 192(12):2092-8. PubMed ID: 16288372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized trial of inactivated and live polio vaccine schedules in Guatemalan infants.
    Asturias EJ; Dueger EL; Omer SB; Melville A; Nates SV; Laassri M; Chumakov K; Halsey NA
    J Infect Dis; 2007 Sep; 196(5):692-8. PubMed ID: 17674310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vaccine-induced mucosal immunity to poliovirus: analysis of cohorts from an open-label, randomised controlled trial in Latin American infants.
    Wright PF; Connor RI; Wieland-Alter WF; Hoen AG; Boesch AW; Ackerman ME; Oberste MS; Gast C; Brickley EB; Asturias EJ; Rüttimann R; Bandyopadhyay AS
    Lancet Infect Dis; 2016 Dec; 16(12):1377-1384. PubMed ID: 27638357
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intestinal immunity is a determinant of clearance of poliovirus after oral vaccination.
    Wright PF; Wieland-Alter W; Ilyushina NA; Hoen AG; Arita M; Boesch AW; Ackerman ME; van der Avoort H; Oberste MS; Pallansch MA; Burton AH; Jaffar MA; Sutter RW
    J Infect Dis; 2014 May; 209(10):1628-34. PubMed ID: 24459191
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metagenomic sequencing of stool samples in Bangladeshi infants: virome association with poliovirus shedding after oral poliovirus vaccination.
    Tan SK; Granados AC; Bouquet J; Hoy-Schulz YE; Green L; Federman S; Stryke D; Haggerty TD; Ley C; Yeh MT; Jannat K; Maldonado YA; Andino R; Parsonnet J; Chiu CY
    Sci Rep; 2020 Sep; 10(1):15392. PubMed ID: 32958861
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serotype-specific mucosal immune response and subsequent poliovirus replication in vaccinated children.
    Samoilovich E; Roivainen M; Titov LP; Hovi T
    J Med Virol; 2003 Oct; 71(2):274-80. PubMed ID: 12938203
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Poliovirus vaccine strains detected in stool specimens of immunodeficient children in South Africa.
    Pavlov DN; Van Zyl WB; Kruger M; Blignaut L; Grabow WO; Ehlers MM
    Diagn Microbiol Infect Dis; 2006 Jan; 54(1):23-30. PubMed ID: 16290028
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serological response and poliovirus excretion following different combined oral and inactivated poliovirus vaccines immunization schedules.
    Parent du Châtelet I; Merchant AT; Fisher-Hoch S; Luby SP; Plotkin SA; Moatter T; Agboatwalla M; McCormick JB
    Vaccine; 2003 Apr; 21(15):1710-8. PubMed ID: 12639494
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibody response and viral excretion after live polio vaccine or a combined schedule of live and inactivated polio vaccines.
    Ramsay ME; Begg NT; Gandhi J; Brown D
    Pediatr Infect Dis J; 1994 Dec; 13(12):1117-21. PubMed ID: 7892081
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of immunoglobulin G levels produced by oral polio vaccine in HIV infected children in Jos, Plateau State, Nigeria.
    Lengkat FA; Chukwudozie OS; Vincent OO; James DM; Amina HG; Kenneth O
    Pan Afr Med J; 2019; 34():183. PubMed ID: 32158512
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral polio vaccine response in the MAL-ED birth cohort study: Considerations for polio eradication strategies.
    Pan WK; Seidman JC; Ali A; Hoest C; Mason C; Mondal D; Knobler SL; Bessong P;
    Vaccine; 2019 Jan; 37(2):352-365. PubMed ID: 30442479
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunogenicity and fecal poliovirus excretion in sequential use of inactivated and oral poliovirus vaccines.
    Lu CY; Kao CL; Lee CY; Lee PI; Huang LM
    J Formos Med Assoc; 2001 Aug; 100(8):513-8. PubMed ID: 11678000
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vaccine-Derived Polioviruses and Children with Primary Immunodeficiency, Iran, 1995-2014.
    Shaghaghi M; Shahmahmoodi S; Abolhassani H; Soleyman-Jahi S; Parvaneh L; Mahmoudi S; Chavoshzadeh Z; Yazdani R; Zahraei SM; Ebrahimi M; Eslamian MH; Tabatabaie H; Yousefi M; Kandelousi YM; Oujaghlou A; Rezaei N; Aghamohammadi A
    Emerg Infect Dis; 2016 Oct; 22(10):1712-9. PubMed ID: 27648512
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in children and infants: two clinical trials.
    Sáez-Llorens X; Bandyopadhyay AS; Gast C; Leon T; DeAntonio R; Jimeno J; Caballero MI; Aguirre G; Oberste MS; Weldon WC; Konopka-Anstadt JL; Modlin J; Bachtiar NS; Fix A; Konz J; Clemens R; Costa Clemens SA; Rüttimann R
    Lancet; 2021 Jan; 397(10268):27-38. PubMed ID: 33308427
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Update on Vaccine-Derived Polioviruses - Worldwide, January 2016-June 2017.
    Jorba J; Diop OM; Iber J; Henderson E; Sutter RW; Wassilak SGF; Burns CC
    MMWR Morb Mortal Wkly Rep; 2017 Nov; 66(43):1185-1191. PubMed ID: 29095803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunodeficiency-related vaccine-derived poliovirus (iVDPV) cases: a systematic review and implications for polio eradication.
    Guo J; Bolivar-Wagers S; Srinivas N; Holubar M; Maldonado Y
    Vaccine; 2015 Mar; 33(10):1235-42. PubMed ID: 25600519
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Shedding of virulent poliovirus revertants during immunization with oral poliovirus vaccine after prior immunization with inactivated polio vaccine.
    Abraham R; Minor P; Dunn G; Modlin JF; Ogra PL
    J Infect Dis; 1993 Nov; 168(5):1105-9. PubMed ID: 8228342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Humoral and intestinal immunity induced by new schedules of bivalent oral poliovirus vaccine and one or two doses of inactivated poliovirus vaccine in Latin American infants: an open-label randomised controlled trial.
    Asturias EJ; Bandyopadhyay AS; Self S; Rivera L; Saez-Llorens X; Lopez E; Melgar M; Gaensbauer JT; Weldon WC; Oberste MS; Borate BR; Gast C; Clemens R; Orenstein W; O'Ryan G M; Jimeno J; Clemens SA; Ward J; Rüttimann R;
    Lancet; 2016 Jul; 388(10040):158-69. PubMed ID: 27212429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral poliovaccine: will it help eradicate polio or cause the next epidemic?
    Shulman LM; Manor Y; Sofer D; Swartz T; Mendelson E
    Isr Med Assoc J; 2006 May; 8(5):312-5. PubMed ID: 16805227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.